MX388182B - Composición para el alivio de la boca seca. - Google Patents

Composición para el alivio de la boca seca.

Info

Publication number
MX388182B
MX388182B MX2017007597A MX2017007597A MX388182B MX 388182 B MX388182 B MX 388182B MX 2017007597 A MX2017007597 A MX 2017007597A MX 2017007597 A MX2017007597 A MX 2017007597A MX 388182 B MX388182 B MX 388182B
Authority
MX
Mexico
Prior art keywords
composition
dry mouth
mouth relief
maintaining
mucosal surface
Prior art date
Application number
MX2017007597A
Other languages
English (en)
Spanish (es)
Other versions
MX2017007597A (es
Inventor
Jerome E Swanson
Original Assignee
Elevate Oral Care Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elevate Oral Care Llc filed Critical Elevate Oral Care Llc
Publication of MX2017007597A publication Critical patent/MX2017007597A/es
Publication of MX388182B publication Critical patent/MX388182B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • A61K31/78Polymers containing oxygen of acrylic acid or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/547Chelates, e.g. Gd-DOTA or Zinc-amino acid chelates; Chelate-forming compounds, e.g. DOTA or ethylenediamine being covalently linked or complexed to the pharmacologically- or therapeutically-active agent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40Cyclodextrins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
MX2017007597A 2014-12-10 2015-11-20 Composición para el alivio de la boca seca. MX388182B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462089942P 2014-12-10 2014-12-10
PCT/US2015/061743 WO2016094054A1 (en) 2014-12-10 2015-11-20 Composition for the relief of dry mouth

Publications (2)

Publication Number Publication Date
MX2017007597A MX2017007597A (es) 2018-03-01
MX388182B true MX388182B (es) 2025-03-19

Family

ID=56107939

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017007597A MX388182B (es) 2014-12-10 2015-11-20 Composición para el alivio de la boca seca.

Country Status (9)

Country Link
US (1) US10772908B2 (enExample)
EP (1) EP3229792B1 (enExample)
JP (1) JP6783244B2 (enExample)
AU (1) AU2015361122B2 (enExample)
CA (1) CA2970146C (enExample)
ES (1) ES2982077T3 (enExample)
MX (1) MX388182B (enExample)
PL (1) PL3229792T3 (enExample)
WO (1) WO2016094054A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3400026A4 (en) 2016-01-10 2019-08-14 Smilesonica Inc. VISCOSITY AND STABILITY-MODIFIED ULTRASOUND GEL
CN105833278B (zh) * 2016-04-25 2018-05-08 北京嘉安医疗器械科技有限公司 用于治疗口腔干燥和口腔疾病的组合物
AU2018225819B2 (en) * 2017-02-22 2023-08-10 Smilesonica Inc. Artificial saliva, related methods, and uses
WO2022081430A1 (en) * 2020-10-15 2022-04-21 Advantage Silver Dental Arrest, Llc A thickened silver diamine fluoride composition

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3970747A (en) * 1974-03-11 1976-07-20 Colgate-Palmolive Company Humectant sweetener
US4340583A (en) * 1979-05-23 1982-07-20 J. M. Huber Corporation High fluoride compatibility dentifrice abrasives and compositions
US4997654A (en) * 1989-08-14 1991-03-05 Warner-Lambert Company Method for increasing salivation for xerostomia patients
US5496558A (en) * 1993-03-02 1996-03-05 Block Drug Company Inc. Solid form xerostomia product
US5900230A (en) * 1997-08-18 1999-05-04 Squigle, Inc. Dental products to treat and prevent periodontal disease
EP1068871A1 (en) * 1999-07-07 2001-01-17 Jean-Paul Perraudin Novel methods and medicament for treating infections diseases involving microbial biofilms
ES2344911T3 (es) 2004-08-02 2010-09-09 Glaxo Group Limited Composicion novedosa para tratar la xerostomia.
WO2009108713A2 (en) * 2008-02-25 2009-09-03 Signum Biosciences, Inc. Topical compositions and methods utilizing peptides containing lipid-modified cysteine-containing peptides
US8735374B2 (en) 2009-07-31 2014-05-27 Intelgenx Corp. Oral mucoadhesive dosage form
JP5433355B2 (ja) * 2009-09-16 2014-03-05 サンスター株式会社 口腔用組成物
US8658139B1 (en) * 2010-02-27 2014-02-25 Squigle, Inc. Prevention and treatment of oral diseases
US20130209376A1 (en) 2010-04-14 2013-08-15 Ips Investments Inc. Oral care compositions
JP5723001B2 (ja) 2010-06-23 2015-05-27 コルゲート・パーモリブ・カンパニーColgate−Palmolive Company 治療用口腔用組成物
US20120053130A1 (en) * 2010-08-30 2012-03-01 Bristol-Myers Squibb Company Composition for enhancing absorption of a drug and method
JP6143675B2 (ja) 2010-12-16 2017-06-07 セルジーン コーポレイション 難溶性薬物の制御放出経口剤形及びその使用
US10449139B2 (en) 2010-12-23 2019-10-22 Colgate-Palmolive Company Aqueous oral care compositions
JP2015501197A (ja) 2011-09-23 2015-01-15 エメラルド・ヒルトン・デイビス,エルエルシー 自己組織化ナノ構造粒子およびその調製方法
CN103974691A (zh) 2011-12-15 2014-08-06 高露洁-棕榄公司 水性口腔护理组合物
US9724542B2 (en) 2012-10-12 2017-08-08 Premier Dental Products Company Remineralizing and desensitizing compositions, treatments and methods of manufacture

Also Published As

Publication number Publication date
PL3229792T3 (pl) 2024-06-10
AU2015361122B2 (en) 2020-12-17
WO2016094054A1 (en) 2016-06-16
AU2015361122A1 (en) 2017-06-22
CA2970146A1 (en) 2016-06-16
EP3229792C0 (en) 2024-02-07
ES2982077T3 (es) 2024-10-14
EP3229792A1 (en) 2017-10-18
EP3229792B1 (en) 2024-02-07
CA2970146C (en) 2023-10-31
MX2017007597A (es) 2018-03-01
JP2017537983A (ja) 2017-12-21
US10772908B2 (en) 2020-09-15
JP6783244B2 (ja) 2020-11-11
EP3229792A4 (en) 2018-08-08
US20170354676A1 (en) 2017-12-14

Similar Documents

Publication Publication Date Title
AR095233A1 (es) Métodos y composiciones para el control de malezas
MX2018004475A (es) Agentes biologicos y su uso en plantas.
MX391216B (es) Composicion farmaceutica que comprende un vector adenoviral.
SA517381769B1 (ar) توليد حمض بيروكسي فورميك من خلال فورمات كحول بولي هيدريك
BR112017006664A2 (pt) terapias de combinação
TWD185242S (zh) 集成的通用串行總線裝置延長線
MX381290B (es) Formulaciones de peróxido y métodos y aplicaciones para utilizarlas.
EA202090632A1 (ru) Способы и композиции для лечения расстройств с использованием фоллистатиновых полипептидов
EA201690280A1 (ru) Композиции и способы, относящиеся к выделенным эндофитам
EA201690613A1 (ru) Улучшенные составы на основе аденовирусов
CL2016003074A1 (es) Compuestos derivados de 2-oxi-2-fenil-n-5-pirrolidin-3-ilamino-1,3,4-tiadiazol-2-ilacetamida, inhibidores gls1 composición farmacéutica y su uso para tratar el cáncer.
MX381544B (es) Composición de células estromales mesenquimatosas para usare en el tratamiento de la sepsis en un sujeto.
PH12017500836A1 (en) Transdermal formulations
MX2022005583A (es) Uso de flujo de azucar en fermentacion de etanol para producir otros productos.
AR099500A1 (es) Composición para el desmucilaginado enzimático de aceite
DK3356524T3 (da) Forøget genlevering til naturlige dræberceller, hæmatopoietiske stamceller og makrofager
WO2016079110A3 (en) Use of enzyme for cleaning
MX388182B (es) Composición para el alivio de la boca seca.
AU2015267160A8 (en) Methods and compositions for preventing ischemia reperfusion injury in organs
AR103119A1 (es) Uso de elsiglutida para tratar mucositis gastrointestinal, incluyendo diarrea inducida por quimioterapia
AU358315S (en) Novelty sconce
CL2016002653A1 (es) Combinación farmacéutica que comprende brexpiprazol y nalmefeno; composición farmacéutica que los comprende; kit farmacéutico; y uso de la combinación para la prevención y tratamiento de un trastorno relacionado con sustancias como el alcohol.
NO20161574A1 (en) Skiwax
MX380683B (es) Lisobactina para su uso en el tratamiento de la mastitis bovina.
EA201690709A1 (ru) Применение одипарцила в лечении мукополисахаридоза